Phototherapy methods and systems

• US 6,436,127 B1
• Filed: 10/08/1998
• Issued: 08/20/2002
• Est. Priority Date: 10/08/1997
• Status: Expired due to Term

• Current Assignee: Massachusetts General Hospital (Mass General Brigham, Inc.), The General Hospital Corporation (Mass General Brigham, Inc.)
• Original Assignee: The General Hospital Corporation (Mass General Brigham, Inc.)
• Inventors: Dwyer, Peter J., Anderson, Richard Rox
• Primary Examiner(s): Shay, David M.
• Application Number:
  US09/169,083
• Time in Patent Office: 1,412 Days
• Field of Search: 606/3, 606/4, 606/7, 606/10-19, 607/88-96, 600/310, 600/317, 604/19, 604/20, 128/898
• US Class Current: 607/89
• CPC Class Codes: A61B 2090/373 using light, e.g. by using optical scanners
• CPC Class Codes: A61B 5/0064 Body surface scanning
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/444 Evaluating skin marks, e.g. mole, nevi, tumour, scar
• CPC Class Codes: A61B 5/445 Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
• CPC Class Codes: A61N 2005/0644 Handheld applicators
• CPC Class Codes: A61N 2005/0661 ultraviolet
• CPC Class Codes: A61N 5/0616 Skin treatment other than tanning
• CPC Class Codes: A61N 5/0617 Hair treatment
• CPC Class Codes: A61N 5/067 using laser light

Abstract

The invention features methods and systems for treating inflammatory, proliferative skin disorders, such as psoriasis, with ultraviolet phototherapy. The methods and systems use optical techniques to scan a patient'"'"'s skin, designate areas of affected skin, and selectively deliver high doses of phototherapeutic ultraviolet radiation to the designated areas. To insure that only affected areas of skin affected are designated for the high doses of UV radiation, the methods and systems use one or more optical diagnostics that relate to independent physiological features of affected skin.

Claims

1. A method for treating a proliferative skin disorder in a patient, the method comprising:

performing at least two different optical diagnostics on a selected area of the patient'"'"'s skin, wherein each diagnostic independently provides a positive indication when the skin disorder is present in the selected area;

determining from the optical diagnostics whether the selected area is affected by the skin disorder based on whether each diagnostic provides the positive indication; and

if the selected area is determined to be affected by the skin disorder, delivering an effective dose of phototherapeutic radiation to the selected area.

2. The method of claim 1, wherein the method is performed in an automated manner.

3. The method of claim 1, wherein the disorder is psoriasis.

4. The method of claim 1, wherein the selected area is less than about 1 cm².

5. The method of claim 1, wherein the phototherapeutic radiation is ultraviolet radiation having a wavelength of about 290 nm to 330 nm, and wherein the effective dose is in the range of about 0.02 J/cm² to 1 J/cm².

6. The method of claim 1, wherein the effective dose is greater than about two minimal erythema doses.

7. The method of claim 1, wherein the effective dose is greater than about three minimal erythema doses.

8. The method of claim 1, wherein the effective dose is greater than about ten minimal erythema doses.

9. The method of claim 1, wherein one of the optical diagnostics relates to diffuse reflectance.

10. The method of claim 1, wherein the at least two different optical diagnostics comprise diffuse reflectance and fluorescence.

11. The method of claim 1, wherein the at least two different optical diagnostics measure different physiological properties of the skin disorder.

12. The method of claim 1, wherein the phototherapeutic radiation is ultraviolet radiation.

13. The method of claim 1, wherein the phototherapeutic radiation is delivered by a laser.

14. The method of claim 13, wherein the laser is a xenon chloride excimer laser.

15. The method of claim 1, wherein one of the optical diagnostics relates to fluorescence.

16. The method of claim 15, wherein the performing step comprises delivering a diagnostic dose of radiation from a source, wherein the diagnostic dose is sufficient to excite the fluorescence from the selected area but is not an effective dose of phototherapeutic radiation, and wherein the delivering step comprises delivering an effective phototherapeutic dose of radiation from the source by increasing fluence of the source.

17. The method of claim 1, further comprising:

constructing a digital map of areas of the patient'"'"'s skin affected by the skin disorder by repeating the performing and determining steps for additional selected areas; and

delivering effective doses of phototherapeutic radiation to at least one of the affected areas indicated on the map.

18. The method of claim 17, wherein the effective doses of phototherapeutic radiation are delivered to each of the affected areas indicated on the map.

19. The method of claim 17, further comprising:

performing an additional optical diagnostic on each of the areas indicated on the map to confirm that these areas are affected and designating the confirmed areas as treatment areas; and

delivering an effective dose of phototherapeutic radiation to at least one of the treatment areas.

20. The method of claim 17, wherein the constructing step is completed before the delivering step.